Samlyn Capital, LLC Xenon Pharmaceuticals Inc. Transaction History

Samlyn Capital, LLC

$6.21 Billion
Q3 2024

A detailed history of Samlyn Capital, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Samlyn Capital, LLC holds 1,020,206 shares of XENE stock, worth $42.1 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,020,206

Previous 639,685 59.49%

Holding current value

$42.1 Million

Previous $24.9 Million 60.96%

% of portfolio

0.65%

Previous 0.44%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $13.7 Million - $16.7 Million	380,521 Added 59.49%	1,020,206 $40.1 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $8.83 Million - $10.7 Million	243,489 Added 61.46%	639,685 $24.9 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $1.06 Million - $1.25 Million	-24,959 Reduced 5.93%	396,196 $17.1 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $15.2 Million - $24.7 Million	-530,600 Reduced 55.75%	421,155 $19.4 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $404,659 - $470,641	11,846 Added 1.26%	951,755 $32.5 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $7.63 Million - $9.54 Million	-219,085 Reduced 18.9%	939,909 $36.2 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $1.17 Million - $1.4 Million	-34,820 Reduced 2.92%	1,158,994 $41.5 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $3.15 Million - $3.76 Million	-95,419 Reduced 7.4%	1,193,814 $47.1 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $5.32 Million - $6.88 Million	172,797 Added 15.48%	1,289,233 $46.5 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $12.4 Million - $17.1 Million	485,707 Added 77.01%	1,116,436 $34 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $2.74 Million - $3.61 Million	109,089 Added 20.91%	630,729 $19.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $8.14 Million - $18.5 Million	521,640 New	521,640 $16.3 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.57B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account

Samlyn Capital, LLC Xenon Pharmaceuticals Inc. Transaction History